Northern Trust Corp Jasper Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$1.19 - $1.79 $448 - $674
-377 Reduced 0.24%
154,909 $212,000
Q1 2023

May 15, 2023
BUY
$1.48 - $2.74 $198,062 - $366,683
133,826 Added 623.61%
155,286 $281,000
Q2 2022

Aug 12, 2022
BUY
$1.73 - $3.86 $2,025 - $4,520
1,171 Added 5.77%
21,460 $41,000
Q4 2021

Feb 08, 2022
BUY
$7.21 - $16.42 $146,283 - $333,145
20,289 New
20,289 $159,000

Others Institutions Holding JSPR

# of Institutions
1
Shares Held
5.63M
Call Options Held
0
Put Options Held
0
View Full List

About Jasper Therapeutics, Inc.

JSPR Quotes by TradingView
  • Ticker JSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,073,300
  • Market Cap $829M
  • Description
  • Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...
More about JSPR
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email